The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury. by Jochen Dutzmann, Robert-Jonathan Musmann, Marco Haertlé, Jan-Marcus Daniel, Kristina Sonnenschein, Andreas Schäfer, Peter Kolkhof, Johann Bauersachs, Daniel G Sedding

Get full text